|
Norris Cancer Hospital
Division of Radiation Oncology
Oscar Streeter, Jr., M.D.,
Chief Physician
The 60-bed, USC/Norris Comprehensive Cancer Center and Hospital is a National Cancer Institute-designated comprehensive cancer center. The environment is unique with basic research and clinical operation in the same building allowing opportunities for translational research. Emphasis is placed on multi-disciplinary, state-of-the-art cancer patient management as well as clinical research involving the surgical, medical and radiation oncologic subspecialties. Private patients are typically referred to the Norris Cancer Hospital from community hospitals and other health centers as well as from the USC University Hospital.
The Norris Division of Radiation Oncology is one of the most modern in Southern California, operating a Varian Clinac 2300C/D liner accelerator with a multi-leaf collimator (MLC) and electronic portal imaging (EPI) and a Varian Clinac 4/100 4-MeV linear accelerator. For radiotherapy simulation, it uses a Varian Ximatron with CT option and a Siemens CT scanner. It also has the BSD 2000 Sigma-60 hyperthermia device in addition to other, specialized treatment devices manufactured in-house. The hospital has installed a Nucletron LDR-Selectron and a Varian VariSource high dose-rate unit replaced its Omnitron predecessor. A variety of highly advanced treatment planning computer systems are used including the ADAC Pinnacle3 planning system, and others which are a direct outgrowth of the pioneering clinical and physics research efforts of the USC Radiation Oncology Faculty. True 3-D virtual simulation and isodose planning, allowing for 3-D conformal radiotherapy treatments, is routinely employed. The Norris Division of Radiation Oncology continues to retain its leadership position through timely additions to its technology.
The Division of Radiation Oncology Research under the direction of Oscar Streeter, M.D., is based at USC/NCH Radiation Oncology. Participation in clinical research protocols of national, co-operative programs such as the Radiation Therapy Oncology Group (RTOG) (Oscar Streeter, M.D.), Southwest Oncology Group (SWOG), Co-operative Ocular Melanoma Study (CMOS) (Zbigniew Petrovich, M.D.) or the Gynecology Oncology Group (GOG) (Vaclav Klement, M.D.) are conducted by this Division. The start of any new approach to managing a specific cancer is here.
Supporting the clinical research effort is the Division of Radiation Oncology Physics under Melvin A. Astrahan, Ph.D. Since 1983, the divisions medical physicists have contributed innovative approaches in radiation oncology. Their major accomplishments include the refinement of stereotactic radiosurgery to the brain using the linear accelerator; the development of the episcleral eye plaque and dosimetry software; design and construction of the prototype transurethral hyperthermia (TUHT) applicator for management of benign prostatic hyperplasia (BPH); and more recently, software development and programming for 3D treatment planning and 3D conformal radiotherapy.
|